Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04683939
Title	Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors
Recruitment	Terminated
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	BioNTech SE
Indications	esophagus adenocarcinoma ovarian mucinous neoplasm ovarian mucinous cystadenocarcinoma lung non-small cell carcinoma ovarian mucinous adenocarcinoma stomach cancer colorectal cancer pancreatic adenocarcinoma endocervical adenocarcinoma biliary tract cancer gastroesophageal junction adenocarcinoma pancreatic cancer
Therapies	BNT141 BNT141 + Gemcitabine + Nab-paclitaxel
Age Groups:	adult \| senior
Covered Countries	USA \| CAN